Prime Medicine, Inc.
Developing 'search and replace' gene editing therapies to treat genetic disorders.
PRME | NDAQ
Overview
Corporate Details
- ISIN(s):
- US74168J1016
- LEI:
- Country:
- United States of America
- Address:
- 60 FIRST ST., 2141 CAMBRIDGE
- Website:
- https://primemedicine.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Prime Medicine, Inc. is a biotechnology company focused on developing and delivering potentially curative gene editing therapies. The company utilizes its proprietary Prime Editing platform, a next-generation technology designed to function like a genetic 'search and replace' tool. This approach allows for the precise correction of faulty DNA by replacing it with a correct sequence, thereby addressing the root cause of disease. Prime Medicine is advancing a pipeline of therapeutic candidates aimed at treating a wide range of debilitating genetic disorders.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Prime Medicine, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Prime Medicine, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Prime Medicine, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
